Active syphilis in HIV infection: A multicentre retrospective survey

Genitourinary Medicine

Volumn 72, Issue 3, 1996, Pages 176-181

  Schofer H ^a   Imhof, M ^b   Thoma Greber, E ^b   Brockmeyer, N H ^b   Hartmann, M ^b   Gerken, G ^b   Pees, H W ^b   Rasokat, H ^b   Hartmann, H ^b   Sadri, I ^b   Emminger, C ^b   Stellbrink, H J ^b   Baumgarten, R ^b   Plettenberg, A ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b NONE

Author keywords

Germany; HIV infection; syphilis

Indexed keywords

ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CEFOTAXIME; CEFTRIAXONE; CLEMIZOLE PENICILLIN; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PENICILLIN G; ROLITETRACYCLINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BISEXUALITY; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEUROSYPHILIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY SYPHILIS; SYPHILIS; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; GERMANY; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; RETROSPECTIVE STUDIES; SYPHILIS; SYPHILIS SERODIAGNOSIS;

EID: 79960431453     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Quinn TC, Groseclose SL, Spence M, Provost V, Hook EW. Evolution of the HIV epidemic among patients attending sexually transmitted disease clinics: a decade of experience. J Infect Dis 1992;165:541-4.
2. Fennema JSA, Van Ameijden EJC, Coutinho RA, Van Doornum GJJ, Henquet CJM, Van den Hoek JAR. HIV prevalence among clients attending a sexually transmitted disease clinic in Amsterdam: the risk for heterosexual transmission. Genitourin Med 1993;69:23-8.
3. Pereira LH, Embil JA, Haase DA, Manley KM. Prevalence of HI-virus in the patient population of a sexual transmitted disease-clinic: Association with syphilis and gonorrhea. Sex Transm Dis 1992;19:115-20.
4. Meurer M, Schulte C, Fröschl M. Seroepidemiologische Beziehung zwischen Syphilis und AIDS. AIDS-Forschung (AIFO) 1987;2:697-9,
5. Schöfer H. Hauterkrankungen bei HIV-Infektion und AIDS. Stuttgart, Schwer Verlag, 1990.
6. Plettenberg A, Bahlmann W, Stoehr A, Meigel W. Klinische und serologische Befunde der Lues bei HIV-infizierten Patienten. Dtsch Med Wschr 1991;116:968-72.
7. Hicks CB. Syphilis and HIV infection. Dermatol Clin 1991; 9:493-501.
8. Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med 1990;113:872-88.
9. Berry CD, Hooton TM, Collier A, Lukehart SA. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987;36:1587-98.
10. Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987; 316:1569-72.
11. Katz DA, Berger JR, Duncan RC. Neurosyphilis: a comparative study of the effects of infection with human immunodeficiency virus. Arch Neurol 1993;50:243-9.
12. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. (Leads from the MMWR, Suppl 15). JAMA 1987;258:1143-54.
13. AIDS-Zentrum. 116. Bericht des AIDS-Zentrums im Robert-Koch-Institut über aktuelle epidemiologische Daten. AIDS-Forschung (AIFO) 1995;10:47-54.
14. Gregory N, Sanchez M, Buchness MR. The spectrum of syphilis in patients with human immunodeficiency virus infection. J Am Acad Dermatol 1990;22:1061-7.
15. Lukehart SA, Hook EW, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HH. Invasion of the central nervous system by treponema pallidum: Implications for Diagnosis and Treatment. Ann Intern Med 1988;109: 855-62.
16. Gjestland T. The Oslo study of untreated syphilis - an epidemiologic investigation of the natural course of untreated syphilis based on a study of the Boeck-Bruusgard material. Acta Derm Venereol 1955;35: Suppl. 34.
17. Chesney AM, Kemp JE. Incidence of Spirochaeta pallida in cerebrospinal fluid during early stage of syphilis. JAMA 1924;83:1725-8.
18. Held JL, Grossman ME. Syphilis associated with human immunodeficiency virus infection. J Am Acad Dermatol 1989;20:295.
19. Hay PE, Clarke JR, Taylor-Robinson D, Goldmeier D. Detection of treponemal DNA in the CSF of patients with syphilis and HIV infection using the polymerase chain reaction. Genitourin Med 1990;66:428-32.
20. Kampmeier RH. Essentials of Syphilology. Philadelphia, JB Lippincott; 1943;148.
21. Young H. Syphilis: new diagnostic directions. Int J STD AIDS 1992;3:391-413.
22. Jurado RL, Campbell J, Martin PD. Prozone phenomenon in secondary syphilis. Arch Intern Med 1993;153:2496-8.
23. Taniguchi S, Osato K, Hamada T. The prozone phenomenon in secondary syphilis. Acta Derm Venereol (Stackh) 1995;75:153-4.
24. Lefevre JC, Bertrand MA, Bauriaud R. Evaluation of the Captia enzyme immunoassays for detection of immunoglobulins G and M to Treponema pallidum in syphilis. J Clin Microbiol 1990;28:1704-7.
25. Ijsselmuiden OE, van der Sluis JJ, Mulder A, Stolz E, Bolton KP, van Eijk RV. An IgM capture enzyme linked immunosorbent assay to detect IgM antibodies to treponemes in patients with syphilis. Genitourin Med 1989; 65:79-83.
26. Schmidt BL, Luger A, Duschet P, Seifert W, Gschnait F. Specific IgM tests in the diagnosis of syphilis. Hautarzt 1994;45:685-9 (German, English abstract).
27. Baker-Zander SA, Hook EW, Bonin P, Handsfield HH, Lukehart SA. Antigens of Treponema pallidum recognised by IgG and IgM antibodies during syphilis in humans. J Infect Dis 1985;151:264-72.
28. Gordon SM, Eaton ME, George R, Larsen S, Lukehart SA, Kuypers J, Marra CM. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994;331:1469-73.
29. Gourevitch MN, Selwyn PA, Davenny K, Buono D, Schoenbaum EE, Klein RS, Friedland GH. Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med 1993;118:350-5.